Search Records

The Government of Canada has put in place emergency measures under the Quarantine Act to slow the introduction and spread of COVID-19 and variants in Canada. Fully vaccinated travellers without signs and symptoms of COVID-19 are not required to quarantine upon entering Canada if they comply with...

Provinces and territories decide how, who and when to vaccinate populations living in their region. They consider advice from a number of expert sources as well as their unique situations to vaccinate the people in their region.

Vaccination is one of the most effective ways to protect our families, communities and ourselves against COVID-19. Evidence indicates that vaccines are very effective at preventing severe illness, hospitalization and death from COVID-19, including against Alpha and Delta variants of concern....

As COVID-19 continues to circulate in Canada and more people are getting vaccinated, different public health measures (PHMs) may be required, based on the level of transmission and other key indicators outlined below. This interim guidance provides considerations for adjusting PHMs in the context...

The World Health Organization (WHO) refers to symptoms lasting for weeks or months after a COVID-19 infection as post COVID-19 condition. Some studies have reported later symptoms in patients with a severe COVID-19 infection. For example, those who were hospitalized or needed intensive care...

People with COVID-19 do not always recognize their early symptoms. Even if you do not have symptoms now, it is possible to transmit COVID-19 before you start showing symptoms or without ever developing symptoms. You need to quarantine (self-isolate) for 14 days at home when you may have been...

This is the guidance document for organized summer activities for children and youth. When operating summer activities during the pandemic, extra care and precautions should be considered to help protect children, youth, staff and communities from COVID-19. When case numbers are down and more...

Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process.